SBH · Insider Trading
Sally Beauty Holdings, Inc.
Every open-market purchase and sale reported by SBH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-09 | Marlo Michelle Cormier Platz | Former SVP & CFO | MIXED | — | −$122.80K |
| 2026-05-15 | Adrianne Lee | SVP & CFO | A | +98,280 deriv. | — |
| 2026-04-22 | Erin Nealy Cox | Director | M | +50,505 | — |
| 2026-01-26 | Diana Sue Ferguson | Director | A | +9,975 deriv. | — |
| 2026-01-26 | Debra Golding Perelman | Director | A | +9,975 deriv. | — |
| 2026-01-26 | Lawrence Molloy | Director | M | +14,532 | — |
| 2026-01-26 | James M Head | Director | A | +9,975 deriv. | — |
| 2026-01-26 | Max R. Rangel | Director | A | +9,975 deriv. | — |
| 2026-01-26 | Rachel Rothe Bishop | Director | M | +14,532 | — |
| 2026-01-26 | Jeffrey N Boyer | Director | M | +14,532 | — |
| 2026-01-26 | Dorlisa K Flur | Director | M | +14,532 | — |
| 2026-01-26 | Erin Nealy Cox | Director | A | +9,975 deriv. | — |
| 2025-12-12 | Kim McIntosh | GVP, CONTROLLER & CAO | Sell | −5,900 | −$92.70K |
| 2025-12-03 | Scott C Sherman | SVP, CLO and CHRO | Sell | −15,000 | −$244.09K |
| 2025-11-18 | Mark Gregory Spinks | President Beauty Systems Group | MIXED | +41,350 | −$349.64K |
| 2025-11-18 | Denise Paulonis | President & CEO | MIXED | +208,150 | −$2.18M |
| 2025-11-18 | Scott C Sherman | SVP, CLO and CHRO | MIXED | +30,154 | −$255.01K |
| 2025-11-18 | Marlo Michelle Cormier Platz | SVP & CFO | MIXED | +48,409 | −$412.45K |
| 2025-11-18 | Kim McIntosh | GVP, CONTROLLER & CAO | MIXED | +10,510 | −$88.94K |
| 2025-11-18 | John Howard Goss JR | SVP & President Sally Beauty | MIXED | +41,350 | −$349.64K |
| 2025-11-07 | John Howard Goss JR | SVP & President Sally Beauty | A | +69,578 deriv. | — |
| 2025-11-07 | Marlo Michelle Cormier Platz | SVP & CFO | A | +75,313 deriv. | — |
| 2025-11-07 | Kim McIntosh | GVP, CONTROLLER & CAO | A | +18,362 deriv. | — |
| 2025-11-07 | Mark Gregory Spinks | President Beauty Systems Group | A | +69,578 deriv. | — |
| 2025-11-07 | Scott C Sherman | SVP, CLO and CHRO | A | +54,785 deriv. | — |
| 2025-11-07 | Denise Paulonis | President & CEO | A | +449,555 deriv. | — |
| 2025-09-08 | Max R. Rangel | Director | Buy | +3,500 | +$49.24K |
| 2025-08-14 | Debra Golding Perelman | Director | Buy | +2,300 | +$31.01K |
| 2025-08-11 | Denise Paulonis | President & CEO | Buy | +4,500 | +$52.83K |
| 2025-08-11 | Diana Sue Ferguson | Director | Buy | +2,500 | +$30.05K |
| 2025-01-27 | James M Head | Director | A | +14,532 deriv. | — |
| 2025-01-27 | Diana Sue Ferguson | Director | A | +14,532 deriv. | — |
| 2025-01-27 | Lawrence Molloy | Director | M | +15,470 | — |
| 2025-01-27 | Rachel Rothe Bishop | Director | M | +15,470 | — |
| 2025-01-27 | Jeffrey N Boyer | Director | M | +15,470 | — |
| 2025-01-27 | Dorlisa K Flur | Director | M | +15,470 | — |
| 2025-01-27 | Erin Nealy Cox | Director | A | +14,532 deriv. | — |
| 2025-01-27 | Debra Golding Perelman | Director | A | +14,532 deriv. | — |
| 2025-01-27 | James Grant Conroy | Director | M | +12,376 | — |
| 2024-11-26 | Scott C Sherman | See Remarks | Sell | −13,500 | −$195.62K |
| 2024-11-26 | Kim McIntosh | GVP, CONTROLLER & CAO | Sell | −4,300 | −$62.48K |
| 2024-11-19 | Mary Beth Beth Edwards | See remarks | MIXED | +20,917 | −$167.28K |
| 2024-11-19 | Mark Gregory Spinks | See remarks | MIXED | +28,204 | −$225.54K |
| 2024-11-19 | Kim McIntosh | GVP, CONTROLLER & CAO | MIXED | +9,713 | −$41.99K |
| 2024-11-19 | Scott C Sherman | See Remarks | MIXED | +20,917 | −$167.28K |
| 2024-11-19 | Denise Paulonis | President & CEO | MIXED | +173,821 | −$1.48M |
| 2024-11-19 | Marlo Michelle Cormier Platz | SVP & CFO | MIXED | +34,713 | −$277.59K |
| 2024-11-19 | John Howard Goss JR | SVP & President Sally Beauty | MIXED | +28,204 | −$225.54K |
| 2024-11-08 | Kim McIntosh | GVP, Controller & CAO | A | +14,448 deriv. | — |
| 2024-11-08 | Scott C Sherman | See Remarks | A | +43,706 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| Denise Paulonis | President & CEO | 607,103 | $11.83M |
| Marlo Michelle Cormier Platz | Former SVP & CFO | 180,916 | $3.53M |
| John Howard Goss JR | SVP & President Sally Beauty | 140,141 | $2.73M |
| Mary Beth Beth Edwards | See remarks | 60,745 | $1.18M |
| Scott C Sherman | SVP, CLO and CHRO | 57,585 | $1.12M |
| Dorlisa K Flur | Director | 57,138 | $1.11M |
| Erin Nealy Cox | Director | 55,969 | $1.09M |
| Jeffrey N Boyer | Director | 42,460 | $827.55K |
| Rachel Rothe Bishop | Director | 36,231 | $706.14K |
| Lawrence Molloy | Director | 30,002 | $584.74K |
| Kim McIntosh | GVP, CONTROLLER & CAO | 21,295 | $415.04K |
| Mark Gregory Spinks | President Beauty Systems Group | 17,915 | $349.18K |
| James Grant Conroy | Director | 12,376 | $241.21K |
| Diana Sue Ferguson | Director | 7,912 | $154.20K |
| Max R. Rangel | Director | 3,500 | $68.22K |
| Debra Golding Perelman | Director | 2,300 | $44.83K |
| James M Head | Director | 51 | $994 |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the SBH quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.